The DVL2 gene helps pass signals that guide how cells grow, move, and organize during early development, especially in the face, spine, limbs, and other tissues. If this gene does not work as expected, those developmental signals can be disrupted. Some people with a harmful variant in the DVL2 gene have Robinow syndrome, which can involve short stature, differences in facial appearance, and changes in the spine, ribs, hands, or genitals. This gene is mainly known in genetics clinics rather than in popular culture.
What is a gene?
A gene is a stretch of DNA that carries instructions your cells use to make molecules or direct processes in the body. Some genes provide the directions for producing proteins, which do much of the work inside cells. Other genes mainly regulate when certain processes take place, where they occur, and how strongly they are active. Taken together, genes influence how the body develops and functions, and they can also affect how you respond to food, stress, or medications. To explore this topic in more detail, you can find more in the LearnHub.
Overview
DVL2Gene function
What if the gene works
The DVL2 gene helps pass signals that guide how cells grow, move, and organize. It is especially important during early development, when tissues and body structures are forming.
Risk
What if the gene does not work
Variants in the DVL2 gene are linked to Robinow syndrome, which can cause short stature, facial differences, and changes in the spine, ribs, hands, or genitals. Milder and severe variants can influence what features appear and how noticeable they are.
Treatment
What does that mean for your treatment
No DVL2-specific treatment or drug choice is currently established for people with a pathogenic variant in the DVL2 gene. The DVL2 gene is being studied in cancer research as part of a cell signaling pathway that helps control growth, but this has not led to guideline-based treatment use.
Gene function
What if the gene works
DVL2 helps cells pass along messages that guide growth, shape, and organization. These signals are especially important while the body is developing, but they also support routine cell behavior later in life. Understanding DVL2 gene function helps explain how cells stay coordinated as tissues form and renew themselves.
The DVL2 gene relays Wnt signaling (a major cell messaging system) from the cell surface inward. This helps cells respond to instructions about growth, timing, and position.
During development, DVL2 helps cells understand where they are in the body plan. This supports the organized formation of tissues and body structures.
DVL2 helps cells line up and face the right way within a tissue. This coordinated orientation supports orderly cell movement and organ shaping.
Signals passed through DVL2 help guide when cells grow, specialize, or move. In everyday tissues, this supports steady, coordinated cell behavior.
What is a variant?
A genetic variant is a minor change in a gene’s DNA sequence. These changes are common and help shape normal differences between people, such as appearance, metabolism, or the way the body reacts to environmental influences. Many variants do not cause any noticeable effect and are simply part of natural genetic variation. In some situations, though, a variant can change how a gene works more significantly and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the DVL2 gene can change the shape, stability, or tail end of the DVL2 protein, which may weaken or misdirect cell signaling in developing tissues. These DVL2 gene variant effects range from milder changes that slightly reduce protein activity to more disruptive variants that create a shortened protein with abnormal interactions. In Robinow syndrome, stronger signaling disruption can be linked to earlier or more noticeable features, although the effect varies.
How variants are linked to conditions
Pathogenic variants in the DVL2 gene cause autosomal dominant Robinow syndrome. Robinow syndrome linked to the DVL2 gene is a rare condition that can affect bone growth and body shape, often with short stature, shorter arms or legs, spine or rib differences, and recognizable facial features. Features vary from person to person. A confirmed pathogenic DVL2 variant can support or establish the diagnosis when the clinical picture fits.
A variant is not necessarily a diagnosis
Genetic variants are a routine part of human biology and are widely seen in the general population. Most do not have a direct impact on health and instead represent natural human diversity. For many genes, carrying a variant associated with a condition indicates a possible link rather than a certain diagnosis, especially when several genes and environmental factors play a role. In some cases, though, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For DVL2, there is not broadly confirmed evidence that specific lifestyle or environmental factors meaningfully increase or lower health risks linked to this gene. In families with a disease-causing DVL2 change, risk is driven mainly by whether that genetic change is present, so a doctor or genetic counselor can help explain personal and family risk.
Inheritance of DVL2 variants
DVL2-related conditions are inherited in an autosomal dominant pattern, which means a person with a disease-causing variant in the DVL2 gene has a 50% chance of passing it to each child. This is the main DVL2 inheritance pattern described for Robinow syndrome linked to this gene. Some people have a new, de novo variant in the DVL2 gene, meaning it arose for the first time in them and was not inherited from either parent. Mothers and fathers can both pass a DVL2 variant to sons or daughters.
What does my DVL2 result mean for my family?
A disease-causing change in the DVL2 gene is linked to a dominant condition called Robinow syndrome, so close relatives such as parents, brothers, sisters, and children may also carry the same change. In families where the change is inherited, each child has a 1 in 2 chance of inheriting it. Some DVL2 changes happen for the first time in one person, so a parent does not always have the same result.
Genetic information
Genetic testing
How you find out about variants
To look for changes in the DVL2 gene, doctors use genetic testing for DVL2 variants on a blood or saliva sample. A lab reads the gene’s DNA code and compares it with the usual sequence to see whether a variant is present. Results may identify a relevant variant or may not find a meaningful change.
When should I consider getting a genetic test?
Genetic testing for the DVL2 gene may be worth considering if a child or adult has signs of Robinow syndrome, such as short stature, distinctive facial features, and hand, spine, or genital differences. It can also help when these features run in the family or when a doctor is trying to confirm the cause.
A genetic result is only one part of your health story
A genetic result can be helpful, but how much it reveals varies by the condition and the type of variant involved. Over time, many factors, including lifestyle, environment, age, and medical history, also influence how the body works. For some conditions, especially those shaped by many genes, genetic information offers context rather than certainty and is most useful when viewed alongside other parts of care. In other situations, a genetic result may give a clear answer. In areas like medication response, genetic results can also help put individual experiences in context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. This helps explain why the same treatment works well for one person, has less effect in another, or causes more side effects in someone else. Small differences in genes can change how the body breaks down a drug, moves it through the body, or responds to it at its target. These differences are common and are one reason medication response can vary from person to person.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences affect the way a person responds to medications. It studies links between genes and drugs to better explain why the same treatment may work differently from one person to another. For many medicines, genes influence both how strongly a drug works and how the body handles it. This understanding can support treatment decisions that are more informed and more individualized. More detail on this topic is available in the LearnHub.
Drugs influenced by the DVL2 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication response, so general concerns about medicines, side effects, or new symptoms are best discussed with your doctor.